These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8650425)

  • 1. [Outcome of cystic fibrosis children screened at birth].
    Brouard J; Travert G; Laroche D; Duhamel JF
    Rev Mal Respir; 1996; 13(1):79-80. PubMed ID: 8650425
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.
    Dankert-Roelse JE; Mérelle ME
    J Pediatr; 2005 Sep; 147(3 Suppl):S15-20. PubMed ID: 16202775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).
    Siret D; Bretaudeau G; Branger B; Dabadie A; Dagorne M; David V; de Braekeleer M; Moisan-Petit V; Picherot G; Rault G; Storni V; Roussey M
    Pediatr Pulmonol; 2003 May; 35(5):342-9. PubMed ID: 12687590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening: principles and practice.
    Allen DB; Farrell PM
    Adv Pediatr; 1996; 43():231-70. PubMed ID: 8794179
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM
    Adv Pediatr; 2000; 47():79-115. PubMed ID: 10959441
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
    Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
    Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.
    Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E
    Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!
    Farrell PM; Lai HJ; Li Z; Kosorok MR; Laxova A; Green CG; Collins J; Hoffman G; Laessig R; Rock MJ; Splaingard ML
    J Pediatr; 2005 Sep; 147(3 Suppl):S30-6. PubMed ID: 16202779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.
    Comeau AM; Accurso FJ; White TB; Campbell PW; Hoffman G; Parad RB; Wilfond BS; Rosenfeld M; Sontag MK; Massie J; Farrell PM; O'Sullivan BP;
    Pediatrics; 2007 Feb; 119(2):e495-518. PubMed ID: 17272609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis newborn screening: impact of early screening results on parenting stress.
    Baroni MA; Anderson YE; Mischler E
    Pediatr Nurs; 1997; 23(2):143-51. PubMed ID: 9165929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.
    Kloosterboer M; Hoffman G; Rock M; Gershan W; Laxova A; Li Z; Farrell PM
    Pediatrics; 2009 Feb; 123(2):e338-46. PubMed ID: 19171585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales.
    McKay KO; Waters DL; Gaskin KJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S47-50. PubMed ID: 16202782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening policy for cystic fibrosis. The role of evidence.
    Wilfond BS
    Hastings Cent Rep; 1995; 25(3):S21-3. PubMed ID: 7649737
    [No Abstract]   [Full Text] [Related]  

  • 15. Scots launch cystic fibrosis screening for newborns.
    Pract Midwife; 2003 Apr; 6(4):10. PubMed ID: 12715497
    [No Abstract]   [Full Text] [Related]  

  • 16. [Report from the National Observatory on cystic fibrosis in France].
    Blond B
    Soins Pediatr Pueric; 2001 Aug; (201):11. PubMed ID: 11949331
    [No Abstract]   [Full Text] [Related]  

  • 17. Newborn screening for cystic fibrosis: recommendations from the Centers for Disease Control and Prevention.
    Grosse SD; Boyle CA; Cordero JF
    Am Fam Physician; 2005 Apr; 71(8):1482, 1487. PubMed ID: 15864890
    [No Abstract]   [Full Text] [Related]  

  • 18. [Conquering cystic fibrosis: reasons to get angry].
    Griffais R
    Rev Infirm; 2004 Sep; (103):10. PubMed ID: 15517793
    [No Abstract]   [Full Text] [Related]  

  • 19. Newborn screening for cystic fibrosis: an opportunity to improve care and outcomes.
    Campbell PW; White TB
    J Pediatr; 2005 Sep; 147(3 Suppl):S2-5. PubMed ID: 16202776
    [No Abstract]   [Full Text] [Related]  

  • 20. Cystic fibrosis: paediatric aspects.
    Wallis C
    Br J Hosp Med; 1996 Mar 6-19; 55(5):241-7. PubMed ID: 8777514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.